Cargando…

The impact of pulmonary function tests on early postoperative complications in open lung resection surgery: an observational cohort study

We investigated whether pulmonary function tests (PFTs) can predict pulmonary complications and if they are, to find new cutoff values in current open lung resection surgery. In this observational study, patients underwent open lung resection surgery at a tertiary hospital were analyzed (n = 1544)....

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Ji Won, Jeong, Heejoon, Ahn, Hyun Joo, Yang, Mikyung, Kim, Jie Ae, Kim, Duk Kyung, Lee, Sang Hyun, Kim, Keoungah, Choi, Jisun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786949/
https://www.ncbi.nlm.nih.gov/pubmed/35075198
http://dx.doi.org/10.1038/s41598-022-05279-8
Descripción
Sumario:We investigated whether pulmonary function tests (PFTs) can predict pulmonary complications and if they are, to find new cutoff values in current open lung resection surgery. In this observational study, patients underwent open lung resection surgery at a tertiary hospital were analyzed (n = 1544). Various PFTs were tested by area under the receiver-operating characteristic curve (AUC(ROC)) to predict pulmonary complications until 30 days postoperatively. In results, PFTs were generally not effective to predict pulmonary complications (AUC(ROC): 0.58–0.66). Therefore, we could not determine new cutoff values, and used previously reported cutoffs for post-hoc analysis [predicted postoperative forced expiratory volume in one second (ppoFEV(1)) < 40%, predicted postoperative diffusing capacity for carbon monoxide (ppoDL(CO)) < 40%]. In multivariable analysis, old age, male sex, current smoker, intraoperative transfusion and use of inotropes were independent risk factors for pulmonary complications (model 1: AUC(ROC) 0.737). Addition of ppoFEV(1) or ppoDL(CO) < 40% to model 1 did not significantly increase predictive capability (model 2: AUC(ROC) 0.751, P = 0.065). In propensity score-matched subgroups, patients with ppoFEV(1) or ppoDL(CO) < 40% showed higher rates of pulmonary complications [13% (21/160) vs. 24% (38/160), P = 0.014], but no difference in in-hospital mortality [3% (8/241) vs. 6% (14/241), P = 0.210] or mean survival duration [61 (95% CI 57–66) vs. 65 (95% CI 60–70) months, P = 0.830] compared to patients with both > 40%. In conclusion, PFTs themselves were not effective predictors of pulmonary complications. Decision to proceed with surgical resection of lung cancer should be made on an individual basis considering other risk factors and the patient's goals.